Mihaela Cristea
Hematology & Oncology · Orange, CANPI 1417050998
Payments from drug & device makers
Across 49 payments — averaging $30,652 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.4M
- GSK$96K
- E.r. Squibb & Sons, L.L.C.$28K
- AstraZeneca$15K
- Tesaro, Inc.$5K
- AbbVie$1K
- plus $13 from 1 others
What the payments were for
- Consulting fees$9,45059%
- Speaking & faculty fees$4,40027%
- Travel & lodging$1,70111%
- Food & beverage$5293%
- Education$400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 13 | $1,356,222 |
| GSK | 4 | $95,962 |
| E.r. Squibb & Sons, L.L.C. | 4 | $28,308 |
| AstraZeneca | 22 | $14,855 |
| Tesaro, Inc. | 3 | $5,483 |
| AbbVie | 2 | $1,100 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,501,942 in reported general payments places this provider in the 90th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Orange
- Nataliya MarOrange$10.4M
- Deepa JeyakumarOrange$10.4M
- Arash Rezazadeh KalebastyOrange$8.7M
- Misako NagasakaOrange$7.4M
- Sai Hong OuOrange$6.8M
- Catherine CoombsOrange$4.9M
- Ritesh ParajuliOrange$3.7M
- Alain AlgaziSan Francisco$119.2M
- David BerzLos Angeles$43.3M
- Jonathan GoldmanSanta Monica$35.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.